Joon Hyung Jung

Joon Hyung Jung

Auto-generated profile, based on publicly available information

Joon Hyung Jung

Chungbuk National University Hospital

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 July 2024 in Clinical Psychopharmacology and Neuroscience
Verified
Journal Article
Open access
PDF file
JPJunha Park
Junha Park
MBMin Soo Byun
Min Soo Byun
DYDahyun Yi
Dahyun Yi
HAHyejin Ahn
Hyejin Ahn
JJJoon Hyung Jung
Joon Hyung Jung
DLDong Young Lee
Dong Young Lee
Junha Park, Min Soo Byun, Dahyun Yi, Hyejin Ahn, Joon Hyung Jung, Nayeong Kong, Yoon Young Chang, Gijung Jung, Jun-Young Lee, Yu Kyeong Kim, Yun-Sang Lee, Koung Mi Kang, Chul-Ho Sohn, Dong Young Lee; for the KBASE Research Group. Clin Psychopharmacol Neurosci 2024;22:646-54. https://doi.org/10.9758/cpn.24.1189

1 July 2024 in Journal of the Korean Academy of Child and Adolescent Psychiatry
Verified
Journal Article
Open access
PDF file
HJHuiyeong Jeon
Huiyeong Jeon
AHAhjeong Hur
Ahjeong Hur
HLHoyeon Lee
Hoyeon Lee
YSYong-Wook Shin
Yong-Wook Shin
SLSang-Ick Lee
Sang-Ick Lee
JSJung-Woo Son
Jung-Woo Son
Huiyeong Jeon, Ahjeong Hur, Hoyeon Lee, Yong-Wook Shin, Sang-Ick Lee, Chul-Jin Shin, Siekyeong Kim, Gawon Ju, Jeonghwan Lee, Joon Hyung Jung, Seungwon Chung, and Jung-Woo Son. J Korean Acad Child Adolesc Psychiatry 2024;35:197-209. https://doi.org/10.5765/jkacap.240008

17 February 2025 in Annals of Neurology
Verified
Journal Article
Closed access
MKMusung Keum
Musung Keum
MBMin Soo Byun
Min Soo Byun
DYDahyun Yi
Dahyun Yi
HAHyejin Ahn
Hyejin Ahn
GJGijung Jung
Gijung Jung
FGfor the KBASE Research Group
for the KBASE Research Group

27 February 2026 in Journal of Alzheimer’s Disease
Verified
Journal Article
Closed access
MKMinjae Kim
Minjae Kim
MBMin Soo Byun
Min Soo Byun
DYDahyun Yi
Dahyun Yi
HAHyejin Ahn
Hyejin Ahn
GJGijung Jung
Gijung Jung
DLDong Young Lee
Dong Young Lee
Background: Metformin has been proposed to have neuroprotective benefits, but its effects on AD-related brain changes remain unclear and may be influenced by apolipoprotein E ε4 ( APOE4 ) genotype, a major genetic risk factor for AD. Objective: To examine the association between metformin use and in vivo AD pathologies and to evaluate whether APOE4 status moderates these associations in older adults with type 2 diabetes mellitus (T2DM). Methods: This cross-sectional study used baseline data from 76 non-demented older adults with T2DM (aged 55–90 years), who were enrolled in the Korean Brain Aging Study for Early Diagnosis and Prediction of Alzheimer's Disease (KBASE). The participants underwent comprehensive clinical and neuropsychological assessment and multimodal neuroimaging, including global amyloid- β (Aβ) retention ([ 11 C] PiB-PET), inferior temporal tau deposition ([ 18 F] AV-1451 PET), AD-signature cortical thickness (AD-CT), and white matter hyperintensity (WMH) volume. Global cognition was assessed using the Consortium to Establish a Registry for Alzheimer's Disease (CERAD) neuropsychological battery. Results: Among 76 participants, 55 (72%) were metformin users and 21 (28%) were non-users. Metformin use was significantly associated with greater AD-CT, but not with Aβ, tau, or WMH volume. A significant interaction between metformin use and APOE4 status was observed with respect to AD-CT. In APOE4 -stratified analyses, metformin use was significantly associated with greater AD-CT and better global cognition among APOE4 non-carriers, but not among carriers. Conclusions: Our findings indicate that metformin use is associated with greater AD-CT—independently of amyloid or tau pathology—particularly among APOE4 non-carriers, and this structural preservation is accompanied by better cognitive outcomes.

22 January 2026 in Journal of the Korean Academy of Child and Adolescent Psychiatry
Verified
Journal Article
Open access
PDF file
GBGeon-Taek Bae
Geon-Taek Bae
SLSang-Ick Lee
Sang-Ick Lee
CSChul-Jin Shin
Chul-Jin Shin
JSJung-Woo Son
Jung-Woo Son
SKSiekyeong Kim
Siekyeong Kim
SCSeungwon Chung
Seungwon Chung
Geon-Taek Bae, Sang-Ick Lee, Chul-Jin Shin, Jung-Woo Son, Siekyeong Kim, Gawon Ju, Jeonghwan Lee, Joon Hyung Jung, and Seungwon Chung. J Korean Acad Child Adolesc Psychiatry 2026;37:95-104. https://doi.org/10.5765/jkacap.250058

11 February 2025 in Clinical Psychopharmacology and Neuroscience
Verified
Journal Article
Open access
PDF file
GBGihwan Byeon
Gihwan Byeon
MBMin Soo Byun
Min Soo Byun
DYDahyun Yi
Dahyun Yi
HAHyejin Ahn
Hyejin Ahn
GJGijung Jung
Gijung Jung
TGthe KBASE Research Group
the KBASE Research Group
Gihwan Byeon, Min Soo Byun, Dahyun Yi, Hyejin Ahn, Gijung Jung, Bo Kyung Sohn, Joon Hyung Jung, Yoon Young Chang, Kyungtae Kim, Hyeji Choi, Yoon Hee Kim, Yu Kyeong Kim, Koung Mi Kang, Chul-Ho Sohn, Dong Young Lee; for the KBASE Research Group. Clin Psychopharmacol Neurosci 2025;23:256-65. https://doi.org/10.9758/cpn.24.1238